Physician profile
Yasmin Dhar
NPI 1447485941
$19,389.36
in general payments reported to CMS, 2019-2025
33 companies · $857 in 2025
The $857 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $598 · 2021: $1,593 · 2022: $440 · 2023: $3,066 · 2024: $914 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $2,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $2,337.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $13,675.76 | 2019-2023 | |
| Smith+Nephew, INC. | $1,713.30 | 2019-2025 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Gotham Surgical Solutions & Devices, INC. | $1,375.82 | 2021-2025 | |
| Stryker Corporation | $347.92 | 2021-2024 | Mako, Gamma, Accolade |
| Zimmer Biomet Holdings, INC. | $311.72 | 2019-2025 | Comprehensive, Comprehensive Shoulder System, Persona |
| Horizon Therapeutics Plc | $212.35 | 2020-2022 | |
| Pacira Therapeutics, INC. | $210.11 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $190.37 | 2019-2025 | Euflexxa |
| Miach Orthopaedics, INC. | $143.14 | 2024 | |
| Bioventus LLC | $131.50 | 2024-2025 | Durolane, Supartz Fx Sodium Hyaluronate, Gelsyn-3 |
| Depuy Synthes Sales INC. | $128.43 | 2019-2025 | Monovisc |
| Nevro Corp. | $95.27 | 2020-2023 | Senza |
| Fidia Pharma USA INC. | $91.88 | 2019-2024 | Triluron |
| Ermi LLC | $88.02 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $81.25 | 2023-2024 | Iovera, Zilretta, Exparel |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $51.65 | 2019-2020 | |
| Convatec INC. | $47.85 | 2019 | |
| Becton, Dickinson and Company | $45.95 | 2019 | |
| Treace Medical Concepts, INC. | $42.63 | 2025 | |
| Heron Therapeutics, INC. | $41.06 | 2021-2023 | Zynrelef |
| Ibsa Pharma INC. | $40.16 | 2021-2022 | |
| Acell, INC. | $38.01 | 2020 | |
| Vericel Corporation | $37.98 | 2022-2025 | Maci |
| Biocomposites INC | $37.64 | 2024 | |
| Curonix LLC | $37.38 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Endo Pharmaceuticals INC. | $30.48 | 2020-2023 | Xiaflex |
| Endo USA, INC. | $26.53 | 2025 | Xiaflex |
| Medtronic, INC. | $26.09 | 2022 | |
| Axogen | $21.86 | 2022 | |
| Abbott Laboratories | $20.20 | 2019 | |
| Boston Scientific Corporation | $18.13 | 2020 | |
| Globus Medical, INC. | $15.34 | 2021 | |
| Pfizer INC. | $13.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasmin Dhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.